Deaths from opioid-related overdoses continue to grow in the US, but public health events of recent times mean that attention has been focused elsewhere.
Several pharma companies could face criminal charges by federal prosecutors investigating large shipments of opioid painkillers that contributed to the addiction epidemic in the country, ac
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh